• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Amneal Pharmaceuticals, Inc. - Class A Common Stock (NQ:AMRX)

    17.50 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EDT, Jul 20, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 320
    Open 17.50
    Bid (Size) 17.03 (200)
    Ask (Size) 17.73 (100)
    Prev. Close 17.50
    Today's Range 17.50 - 17.50
    52wk Range 7.665 - 18.39
    Shares Outstanding 1,000
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Amneal Expands Iohexol Injection Portfolio with U.S. FDA Approval of Additional Strengths and Presentations
    From Amneal Pharmaceuticals LLC
    Via GlobeNewswire
    News headline image
    3 Reasons AMRX is Risky and 1 Stock to Buy Instead
    Amneal currently trades at $16.70 and has been a dream stock for shareholders. It’s returned 283% since July 2021, blowing past the S&P 500’s 72.3% gain. The... 
    Via StockStory
    Topics Stocks

    Performance

    YTD
    +38.2%
    +38.2%
    1 Month
    +8.6%
    +8.6%
    3 Month
    +32.0%
    +32.0%
    6 Month
    +31.3%
    +31.3%
    1 Year
    +121.2%
    +121.2%

    More News

    Read More
    News headline image
    Amneal to Report Second Quarter 2026 Results on July 30, 2026
    From Amneal Pharmaceuticals LLC
    Via GlobeNewswire
    News headline image
    Generic Pharmaceuticals Stocks Q4 In Review: Amneal (NASDAQ:AMRX) Vs Peers
    Via StockStory
    Topics Artificial Intelligence Intellectual Property
    News headline image
    1 Mooning Stock Worth Your Attention and 2 We Question
    Via StockStory
    News headline image
    1 Small-Cap Stock for Long-Term Investors and 2 We Find Risky
    Via StockStory
    News headline image
    3 Russell 2000 Stocks with Open Questions
    Via StockStory
    News headline image
    Amneal Pharmaceuticals Bets on Biosimilars, Patches to Power Next Growth Phase ↗
    Via MarketBeat
    News headline image
    Amneal Announces Full Study Population Interim Phase 4 ELEVATE-PD Results, Reinforcing Previously Reported Benefits of CREXONT® in Parkinson's Disease
    From Amneal Pharmaceuticals LLC
    Via GlobeNewswire
    News headline image
    Why Amneal (AMRX) Stock Is Trading Up Today
    Via StockStory
    News headline image
    Amneal Announces U.S. FDA Approval of Romidepsin Injection Solution
    From Amneal Pharmaceuticals LLC
    Via GlobeNewswire
    News headline image
    3 Profitable Stocks with Open Questions
    Via StockStory
    Topics Economy
    News headline image
    Amneal to Participate in Goldman Sachs 47th Annual Global Healthcare Conference 2026
    From Amneal Pharmaceuticals LLC
    Via GlobeNewswire
    News headline image
    Q4 Earnings Highlights: Amneal (NASDAQ:AMRX) Vs The Rest Of The Generic Pharmaceuticals Stocks
    Via StockStory
    Topics Artificial Intelligence Intellectual Property
    News headline image
    2 Reasons AMRX is Risky and 1 Stock to Buy Instead
    Via StockStory
    Topics Artificial Intelligence Stocks
    News headline image
    Amneal Reports First Quarter 2026 Financial Results
    From Amneal Pharmaceuticals LLC
    Via GlobeNewswire
    News headline image
    Amneal (AMRX) Q3 2025 Earnings Call Transcript ↗
    Via The Motley Fool
    Topics Earnings
    News headline image
    Amneal (AMRX) Q2 2025 Earnings Transcript ↗
    Via The Motley Fool
    Topics Supply Chain
    News headline image
    1 Value Stock to Target This Week and 2 Facing Challenges
    Via StockStory
    News headline image
    Amneal (AMRX) Q1 2026 Earnings Transcript ↗
    Via The Motley Fool
    News headline image
    Amneal (AMRX) Q1 Earnings Report Preview: What To Look For
    Via StockStory
    News headline image
    Kashiv BioSciences Agrees to Be Acquired by Amneal Pharmaceuticals to Create a Fully Integrated Global Biosimilar Leader
    From Kashiv BioSciences, LLC
    Via Business Wire
    News headline image
    Amneal Agrees to Acquire Kashiv BioSciences to Create Global Biosimilar Leader; Reports Strong Preliminary First Quarter 2026 Financial Results and Raises FY2026 Standalone Guidance
    From Amneal Pharmaceuticals LLC
    Via GlobeNewswire
    News headline image
    Amneal Announces Additional Positive Interim Phase 4 ELEVATE-PD Results with CREXONT® for Parkinson’s Disease, Including Over 3 More Hours of Daily “Good On” Time When Switching from RYTARY®
    From Amneal Pharmaceuticals LLC
    Via GlobeNewswire
    News headline image
    Bruker, Amneal, Amphastar Pharmaceuticals, Dentsply Sirona, and PacBio Stocks Trade Up, What You Need To Know
    Via StockStory
    Topics Economy

    Frequently Asked Questions

    Is Amneal Pharmaceuticals, Inc. - Class A Common Stock publicly traded?
    Yes, Amneal Pharmaceuticals, Inc. - Class A Common Stock is publicly traded.
    What exchange does Amneal Pharmaceuticals, Inc. - Class A Common Stock trade on?
    Amneal Pharmaceuticals, Inc. - Class A Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Amneal Pharmaceuticals, Inc. - Class A Common Stock?
    The ticker symbol for Amneal Pharmaceuticals, Inc. - Class A Common Stock is AMRX on the Nasdaq Stock Market
    What is the current price of Amneal Pharmaceuticals, Inc. - Class A Common Stock?
    The current price of Amneal Pharmaceuticals, Inc. - Class A Common Stock is 17.50
    When was Amneal Pharmaceuticals, Inc. - Class A Common Stock last traded?
    The last trade of Amneal Pharmaceuticals, Inc. - Class A Common Stock was at 07/20/26 04:00 PM ET
    What is the market capitalization of Amneal Pharmaceuticals, Inc. - Class A Common Stock?
    The market capitalization of Amneal Pharmaceuticals, Inc. - Class A Common Stock is 17.50K
    How many shares of Amneal Pharmaceuticals, Inc. - Class A Common Stock are outstanding?
    Amneal Pharmaceuticals, Inc. - Class A Common Stock has 18K shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.